Research projects
Cima Universidad de Navarra
-
Hepatology: Liquid Biopsy and CarcinogenesisActive
PID2022-137181OB-I00 Characterization of SLU7 proteome and interactome and their rewiring in carcinogenesis: from epigenetics to protein stability (SLUTOME)
Cima Principal Investigator: Carmen Berasain Lasarte -
Translational OncologyActive
The innate immune system as a therapeutic target in lung tumors resistant to immunotherapy based on PD-1/PD-L1 blockade
Cima Principal Investigators: Rubén Pío Osés, Daniel Ajona Martínez-PoloFunder: Instituto de Salud Carlos IIIAward year 2023 -
DNA and RNA MedicineActive
MCI PID2022-137327OA-I00 IntegrAAV
Cima Principal Investigator: Carmen UnzuFunder: Ministerio de Ciencia, Innovación y Universidades -
Therapeutic Non-Coding RNA, Microproteins and Integrated Stress in CancerActive
Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
Cima Principal Investigator: Josepmaría ArgemíFunder: Ministerio de Ciencia, Innovación y Universidades -
Vaccine DevelopmentActive
Combination immunotherapies against hepatocarcinoma: modulation of the lymphoid and myeloid compartments
Cima Principal Investigator: Pablo Sarobe UgarrizaFunder: Instituto de Salud Carlos IIIAward year 2024 -
Locoregional Immunotherapy Strategies in Peritoneal CarcinomatosisActive
Virotherapy armed with immunostimulatory genes for the treatment of peritoneal carcinomatosis: The omentum as a “checkpoint” in intraperitoneal treatment
Cima Principal Investigator: Fernando Aranda VegaFunder: Instituto de Salud Carlos IIIAward year 2024 -
Locoregional Immunotherapy Strategies in Peritoneal CarcinomatosisActive
Innovative Translational Research of immunotherapy strategies in ovarian cancer
Cima Principal Investigator: Fernando Aranda VegaFunder: Instituto de Salud Carlos III -
Heart FailureActive
Inflammation and Cardiovascular Damage in Lung Cancer: Studying the Role of Immunomodulatory Therapies in Reducing Cardiotoxicity and Vascular Injury. "InCaRe"
Cima Principal Investigators: Arantxa González Miqueo [SP], Álvaro Teijeira SánchezFunder: Instituto de Salud Carlos IIIAward year 2024 -
AptamersActive
Selective blockade of the IL6/STAT3/SMG1 pathway in multiresistant circulating tumor cells (CTCs) as a pathway of sensitization to oncoimmunotherapy
Cima Principal Investigator: Fernando Pastor RodríguezFunder: Instituto de Salud Carlos IIIAward year 2023 -
Gene Therapy in Neurological DiseasesActive
Characterization of peripheral innate immunity in Amyotrophic Lateral Sclerosis
Cima Principal Investigator: Marisol Aymerich Soler [SP]Funder: Gobierno de Navarra / Departamento de SaludAward year 2024